Improves grip strength, core stability, and gait mechanics all of which decline with muscle loss
In contrast, it is only recently that a drug, which also activates the receptor for the other incretin, glucose-dependent insulinotropic polypeptide (GIP), has been approved for the treatment of T2DM (i.e., tirzepatide, a dual GLP-1/GIP receptor agonist) (Le Roux et al., 2023)
Springer International Publishing, Cham (2018)
Devos, D
Hou L, Klann E (2004) Activation of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin signaling pathway is required for metabotropic glutamate receptor-dependent long-term depression
A potential pro for Lillys pill is that it has no food or water-related restrictions